Cyrus Biotechnology, Inc.

Seattle, WA

UEI
VLHZAL9WY776
CAGE
760V8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Hispanic American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3005 1st Ave Suite 203, Seattle, WA 98121, USA
Website
cyrusbio.com
Founded
2014
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Optimization, pharmacokinetics, and efficacy of an IGG protease for the treatment of immune thrombocytopenia and… R43AI188988 National Institute of Allergy and Infectious Diseases (NIH) $600,000
Advanced uricase engineering for improved outcomes in gout patients R43AR084989 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $298,915
Optimization of a broad and potent decoy receptor for sars-associated viruses R43AI162329 National Institute of Allergy and Infectious Diseases (NIH) $609,111
An easy-to-use and powerful tool for improved rosetta comparative modeling of proteins R43GM116233 National Institutes of Health $224,908

Similar vendors

Vendor Location Primary NAICS
Ubiquitx Inc. UEI LRA7LGJCZP15 New York, NY 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
IPI UEI K34YUEJKPN64 Boston, MA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Invvax, Inc. UEI XD11NMF7NB14 Cypress, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Nectagen Inc. UEI KAFMLCY56WM3 Lawrence, KS 325414 Biological Product (except Diagnostic) Manufacturing
A-Alpha Bio Inc. UEI HCTNBH41FKL1 Seattle, WA 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Cyrus Biotechnology, Inc. is a minority-owned, small disadvantaged business located in Seattle, Washington, registered in the System for Award Management (SAM) since June 2014. The company specializes in computational protein design and biotechnology research, focusing on developing advanced therapeutic protein solutions for various medical conditions. Through its innovative approach, Cyrus Biotechnology leverages artificial intelligence and computational modeling to engineer protein variants with improved pharmacological characteristics, such as reduced immunogenicity, enhanced stability, and extended half-life.

The company has received multiple federal grant awards from prominent research agencies, including the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). These grants support critical research projects in areas such as developing an immunoglobulin G (IgG) protease enzyme for treating immune thrombocytopenia, engineering uricase variants for gout treatment, and creating a broad decoy receptor for SARS-associated viruses. Specifically, Cyrus Biotechnology has been awarded project grants totaling approximately $598,915, with research focusing on computational protein design, therapeutic protein engineering, and addressing challenging medical conditions. The company's research involves sophisticated techniques like deep mutagenesis, computational modeling to remove antigenic epitopes, and fusion protein strategies to improve protein therapeutics' efficacy and safety.

Quick answers

Is Cyrus Biotechnology, Inc. registered in SAM.gov?

Cyrus Biotechnology, Inc.'s SAM.gov registration expired on August 19, 2026.

What is Cyrus Biotechnology, Inc.'s CAGE code?

Cyrus Biotechnology, Inc.'s CAGE code is 760V8, and its Unique Entity ID (UEI) is VLHZAL9WY776.

What is Cyrus Biotechnology, Inc.'s most recent federal award?

Cyrus Biotechnology, Inc.'s most recent federal grant award is Optimization, pharmacokinetics, and efficacy of an IGG protease for the treatment of immune thrombocytopenia and… (R43AI188988), from National Institute of Allergy and Infectious Diseases (NIH), on December 20, 2024.

On GovTribe

See Cyrus Biotechnology, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe